Evidence map›Paper›PMID 31360694›Full record

ReviewCanadian journal of gastroenterology & hepatology2019

An Update on Clinicopathological and Molecular Features of Plexiform Fibromyxoma.

Hsuan-An Su, Hsu-Heng Yen, Chih-Jung Chen

Abstract readReview
In one paragraph

Review in Canadian journal of gastroenterology & hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Gastric Plexiform Fibromyxoma Presenting With Gastrointestinal Hemorrhage.The Korean journal of helicobacter and upper gastrointestinal research · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Plexiform Angiomyxoid Myofibroblastic Tumor (PAMT) of the Stomach: an Extremely Rare Mesenchymal Tumor Masquerading as Gastrointestinal Stromal Tumor or Leiomyoma.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2021
    Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Gastric plexiform fibromyxoma: A case report.World journal of clinical cases · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hsuan-An SuDepartment of Medical Education, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.ORCID 0000-0002-6710-9911
Hsu-Heng YenEndoscopy Center, Changhua Christian Hospital, Changhua, Taiwan.ORCID 0000-0002-3494-2245
Chih-Jung ChenSchool of Medicine, Chung Shan Medical University, Taichung, Taiwan.ORCID 0000-0002-2056-5821

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plexiform fibromyxoma is a rare and newly described gastric mesenchymal tumor with only 121 reported cases in the literature. Our understanding of plexiform fibromyxoma requires updating since the first case has been reported by Takahashi et al. 12 years ago. The present review summarized reported cases in the literature, and both clinical and pathological aspects of plexiform fibromyxoma were comprehensively discussed. Plexiform fibromyxoma usually causes nonspecific or bleeding signs or symptoms, and therefore clinical recognition of the disease is challenging. Plexiform fibromyxoma is of benign nature without any metastasis or recurrence reported, and more conservative surgical treatment should be considered.

Indexed as

FibromaHumansStomach Neoplasms

Identifiers

PMID31360694
PMCPMC6642755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.